ctrl K

Watchlist Price Alert

Maravai LifeSciences Inc... (MRVI)

NASDAQ: MRVI · Real-Time Price · USD

2.23

0.10 (4.69%)

At close: Jun 03, 2025, 3:59 PM

2.22

-0.22%

After-hours: Jun 03, 2025, 04:20 PM EDT

Maravai LifeSciences Revenue Breakdown

Period Ending	Dec 31, 2024	Dec 31, 2023
Biologics Safety Testing Segment Revenue	62.84M	64.18M
Biologics Safety Testing Segment Revenue Growth	-2.09%	n/a
Nucleic Acid Production Segment Revenue	196.34M	224.77M
Nucleic Acid Production Segment Revenue Growth	-12.65%	n/a

Revenue by Geography

Period Ending	Dec 31, 2024	Dec 31, 2023
Asia Pacific Revenue	89.38M	97.44M
Asia Pacific Revenue Growth	-8.27%	n/a
Emea Revenue	42.05M	49.92M
Emea Revenue Growth	-15.76%	n/a
Latin And Central America Revenue	662K	527K
Latin And Central America Revenue Growth	+25.62%	n/a
North America Revenue	127.09M	141.06M
North America Revenue Growth	-9.90%	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Selling, General, and Administrative Revenue	39.56M	41.24M	39.09M	40.56M	31.2M	33.63M	38.86M	35.38M	38.67M	37.2M	30.8M	28.06M	33.2M	25.58M	25.19M	24.09M	23.24M	41.62M	20.51M	15.99M	16.13M	15.78M
Selling, General, and Administrative Revenue Growth	-4.07%	+5.52%	-3.62%	+30.00%	-7.22%	-13.48%	+9.86%	-8.52%	+3.95%	+20.81%	+9.74%	-15.48%	+29.78%	+1.56%	+4.58%	+3.65%	-44.17%	+102.93%	+28.28%	-0.86%	+2.17%	n/a
Research and Development Revenue	4.89M	4.56M	4.34M	5.28M	5.03M	4.59M	4.35M	4.19M	4.14M	5.01M	5.39M	4.27M	3.69M	9.18M	1.95M	1.93M	2.16M	2.09M	1.87M	1.6M	3.74M	979K
Research and Development Revenue Growth	+7.17%	+5.00%	-17.79%	+5.01%	+9.53%	+5.68%	+3.65%	+1.18%	-17.28%	-7.01%	+26.09%	+15.67%	-59.77%	+370.97%	+0.93%	-10.72%	+3.44%	+11.99%	+16.75%	-57.26%	+282.43%	n/a